Evaluation of Effect of Silvernanoparticle Treated Implant on Bone Formation

은나노 처리된 임플란트의 골조직 형성에 미치는 효과 평가

  • Kim, Sin-Guen (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine) ;
  • Yoon, Youn-Jin (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine) ;
  • Lee, Young-Man (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine) ;
  • Lee, Tae-Sun (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine) ;
  • Choi, Dong-Won (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine) ;
  • Song, Yun-Jung (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine) ;
  • Park, Jun-Woo (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine) ;
  • Choi, Dong-Ju (Department of Oral and Maxillofacial Surgery, Hallym University College of Medicine)
  • 김신근 (한림대학교 의과대학 구강악안면외과학교실) ;
  • 윤연진 (한림대학교 의과대학 구강악안면외과학교실) ;
  • 이영만 (한림대학교 의과대학 구강악안면외과학교실) ;
  • 이태선 (한림대학교 의과대학 구강악안면외과학교실) ;
  • 최동원 (한림대학교 의과대학 구강악안면외과학교실) ;
  • 송윤정 (한림대학교 의과대학 구강악안면외과학교실) ;
  • 박준우 (한림대학교 의과대학 구강악안면외과학교실) ;
  • 최동주 (한림대학교 의과대학 구강악안면외과학교실)
  • Received : 2012.05.21
  • Accepted : 2012.07.24
  • Published : 2012.07.31

Abstract

Purpose: To evaluate the effect of silvernanopartilce treated implants on the bone formation and osseointegration. Methods: Silvernanoparticle was produced using an anodic oxidation method. The size of silvernanoparticle ranged from 3.5 nm to 5.9 nm. To check the effect of the capability of osseointegration of silvernanoparticle coated Implant, 32 implants (16 piece of Implant treated with nanoparticle, and 16 piece of Implant was not treated for control) were placed at both the tibia of 8 New Zealand white rabbits. After 4 weeks, 4 rabbits were sacrificed and the removal torque was measured for comparison of the osseointagration ability. Further, 4 rabbits were sacrificed and sliced samples were made. H&E stain was done for microscopic finding. Results: The removal torque of the experimental group was $102.37{\pm}30.54$ N/cm, and the control group was $73.30{\pm}19.97$ N/cm. It was statistically significant (P<0.001). Microscopic finding also shows extinguish results in silvernanoparticle treated implants. Bone formation rate of the experimental group was 43.94% and the control group was 7.58%. It was observed to be statistically significant (P=0.017). Bone to implant contact rate of the experimental group was 58.09%, and the control group was 19.43%. It was found with statistical significance (P<0.001). Conclusion: The silvernanopartilce treated implant shows a better capability of bone regeneration and osseointegration than the non-treated one. Technology to produce smaller particles would make silver more useful and safer.

Keywords

References

  1. Adell R. Tissue integrated prostheses in clinical dentistry. Int Dent J 1985;35:259-65.
  2. Fiske J, Davis DM, Frances C, Gelbier S. The emotional effects of tooth loss in edentulous people. Br Dent J 1998;184:90-3. https://doi.org/10.1038/sj.bdj.4809551
  3. Payne CM, Bladin C, Colchester AC, Bland J, Lapworth R, Lane D. Argyria from excessive use of topical silver sulphadiazine. Lancet 1992;340:126.
  4. Wan AT, Conyers RA, Coombs CJ, Masterton JP. Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 1991;37:1683-7.
  5. Wadhera A, Fung M. Systemic argyria associated with ingestion of colloidal silver. Dermatol Online J 2005;11:12.
  6. Silver S, Phung le T, Silver G. Silver as biocides in burn and wound dressings and bacterial resistance to silver compounds. J Ind Microbiol Biotechnol 2006;33:627-34. https://doi.org/10.1007/s10295-006-0139-7
  7. Klasen HJ. Historical review of the use of silver in the treatment of burns. I. Early uses. Burns 2000;26:117-30. https://doi.org/10.1016/S0305-4179(99)00108-4
  8. Moyer CA. Some effects of 0.5 per cent silver nitrate and high humidity upon the illness associated with large burns. J Natl Med Assoc 1965;57:95-100.
  9. Moyer CA, Brentano L, Gravens DL, Margraf HW, Monafo WW Jr. Treatment of large human burns with 0.5 per cent silver nitrate solution. Arch Surg 1965;90:812-67. https://doi.org/10.1001/archsurg.1965.01320120014002
  10. Klasen HJ. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000;26:131-8. https://doi.org/10.1016/S0305-4179(99)00116-3
  11. Frost HM. Bone histomorphometry: analysis of trabecular bone dynamics. In: Recker RR, editor. Bone histomorphometry: technique and interpretation. Boca Raton, FL: CRC Press; 1993. p.53-87.
  12. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987;2:595-610.
  13. Nischala K, Rao TN, Hebalkar N. Silica-silver core-shell particles for antibacterial textile application. Colloids Surf B Biointerfaces 2011;82:203-8. https://doi.org/10.1016/j.colsurfb.2010.08.039
  14. Cao XL, Cheng C, Ma YL, Zhao CS. Preparation of silver nanoparticles with antimicrobial activities and the researches of their biocompatibilities. J Mater Sci Mater Med 2010;21:2861-8. https://doi.org/10.1007/s10856-010-4133-2
  15. Elechiguerra JL, Burt JL, Morones JR, et al. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnology 2005;3:6. https://doi.org/10.1186/1477-3155-3-6
  16. Forster MJ, Mulloy B, Nermut MV. Molecular modelling study of HIV p17gag (MA) protein shell utilising data from electron microscopy and X-ray crystallography. J Mol Biol 2000;298:841-57. https://doi.org/10.1006/jmbi.2000.3715
  17. Arthur LO, Bess JW Jr, Sowder RC 2nd, et al. Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 1992;258:1935-8. https://doi.org/10.1126/science.1470916
  18. Sung JH, Ji JH, Park JD, et al. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 2009;108:452-61. https://doi.org/10.1093/toxsci/kfn246
  19. Sung JH, Ji JH, Yoon JU, et al. Lung function changes in Sprague-Dawley rats after prolonged inhalation exposure to silver nanoparticles. Inhal Toxicol 2008;20:567-74. https://doi.org/10.1080/08958370701874671
  20. Hussain SM, Schlager JJ. Safety evaluation of silver nanoparticles: inhalation model for chronic exposure. Toxicol Sci 2009;108:223-4. https://doi.org/10.1093/toxsci/kfp032
  21. Cha K, Hong HW, Choi YG, et al. Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles. Biotechnol Lett 2008;30:1893-9. https://doi.org/10.1007/s10529-008-9786-2
  22. Chaby G, Viseux V, Poulain JF, De Cagny B, Denoeux JP, Lok C. Topical silver sulfadiazine-induced acute renal failure. Ann Dermatol Venereol 2005;132:891-3. https://doi.org/10.1016/S0151-9638(05)79509-0
  23. Trop M. Silver-coated dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 2006;61:1024. https://doi.org/10.1097/01.ta.0000240252.08306.7f
  24. Dunn K, Edwards-Jones V. The role of Acticoat with nanocrystalline silver in the management of burns. Burns 2004;30 Suppl 1:S1-9. https://doi.org/10.1016/S0305-4179(04)90000-9